Certified by Founder Lodge
AvenCell
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $112,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 22 ,2024 | Series B | $112,000,000 |
Eight Roads
F-Prime Capital
Novo Holdings
NYBC Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Cascade AI | $3,750,000 | (Oct 25, 2024)
OLOID | $6,000,000 | (Oct 25, 2024)
Outrider | $62,000,000 | (Oct 25, 2024)
Attention | $14,000,000 | (Oct 25, 2024)
Aether Energy (YC W24) | $2,500,000 | (Oct 25, 2024)
